Feb 9 | News
SAN JOSE, Calif.--(BUSINESS WIRE)--Alverix announced today
that BD (Becton, Dickinson and Company) has received approval from the Japanese
Ministry of Health, Labour, and Welfare (MHLW) for the BD Veritor™ System Flu
A+B Test. The BD Veritor System was developed...
|
Feb 5 | News
(Wellcome Trust) A genetic variant that increases the risk of a common type of stroke has been identified by scientists in a study published online in Nature Genetics today. This is one of the few genetic variants to date to be associated with risk of stroke and the discovery opens...
|
Feb 2 | News
DUBLIN--(BUSINESS
WIRE)--Over the last twelve months, medical technology companies publically
announced the investment of approximately €170m and the creation of an
estimated 875 jobs in Ireland over the coming years, according to the Irish
Medical Device Association (IMDA)...
|
Feb 1 | News
Stouffville, Ontario—Following Health Canada
approval, the Zenith Low Profile AAA
Endovascular Graft (Zenith AAA LP) from Cook Medical is now approved and
will be launched to physicians in Canada. With a low-profile delivery
system diameter of 18 Fr and simplified deployment...
|
Jan 26 | News
Singapore - (JCN Newswire) - A Cambridge University research
team has for the first time discovered a method of generating different types
of vascular smooth muscle cells (SMCs) - the cells which make up the walls of
blood vessels - using cells from patients' skin. This work could lead...
|
Jan 25 | News
GATWICK, England--(BUSINESS
WIRE)--Wound care clinicians’ calls for better diagnostic tools to aid
wound assessment have today been answered with the CE marking of WOUNDCHEK™ Protease Status, the world’s first rapid,
point-of-care diagnostic test developed specifically for chronic wounds.
|
Jan 25 | News
Less than a week after Genzyme's Framingham plant landed approval from the European Medicines Agency to manufacture Fabrazyme, the U.S. Food and Drug Administration has also given the OK to produce the treatment for Fabry disease.
|
Jan 25 | News
Advanced Cell Technology Inc. today released data from a U.S. clinical trial testing the safety of treating Stargardt's macular dystrophy with human embryonic stem cell-derived retinal pigment epithelium (RPE) cells.
|
Dec 28 2011 | News
Sunovion Pharmaceuticals, which is owned by Japanese drug maker Dainippon Sumitomo Pharma, confirmed last week that it will lay off an undisclosed number of sales representatives that are responsible for selling the company’s asthma drugs.
|
Dec 24 2011 | News
Momenta Pharmaceuticals Inc., a Cambridge-based developer of novel and generic drugs, has formed a $33 million collaboration deal with Baxter International Inc. that could balloon to more than $450 million with possible milestone payments included.
|
Dec 23 2011 | News
Momenta Pharmaceuticals Inc., a Cambridge-based developer of novel and generic drugs, has formed a $33 million collaboration deal with Baxter International Inc. that could balloon to more than $480 million including possible milestone payments.
|
Dec 22 2011 | News
Curis Inc. has $6 million more in its coffers from a milestone payment after its collaborator Roche submitted its small molecule cancer drug candidate, vismodegib, to the European Medicines Agency for approval in treating advanced basal cell carcinoma.
|
Dec 21 2011 | News
(University of Edinburgh) Scots of Pakistani origin are 50 percent more likely to be admitted to hospital with chest pain and angina than those of Indian ethnicity, a study has found.Scots of Indian and Pakistani origin also have much greater levels of hospital admissions for both...
|
Dec 21 2011 | News
Millennium: The Takeda Oncology Company will add two cancer drug candidates as part of Japanese parent Takeda Pharmaceutical Company Ltd.'s acquisition of Intellikine Inc. of La Jolla, Calif., Takeda said today.
|
Dec 21 2011 | News
(Inderscience Publishers) A lack of infrastructure in developing countries, and particularly in rural areas, often ensures that healthcare provision is absent. Research published in the International Journal of Services, Economics and Management by a team at Howard University in...
|
Dec 21 2011 | News
(University of Western Ontario) The first and only preventative HIV vaccine based on a genetically modified killed whole virus has received approval by the United States Food and Drug Administration (FDA) to start human clinical trials.Developed by Dr. Chil-Yong Kang and his team...
|
Dec 21 2011 | News
(Elsevier Health Sciences) According to a new study published in the Archives of Physical Medicine and Rehabilitation, beginning aquatic therapy just six days after total knee arthroplasty may lead to improved results, while delaying its onset an additional week may be more...
|